# MedQA - Qwen-2.5-7B

- Task: `medqa`
- Model: `qwen_2_5_7b` (Qwen-2.5-7B)
- Stage: `dynamic`
- Source: `trained_models/medqa/qwen_2_5_7b/dynamic`

## Optimized prompt

```
Given the fields `text`, produce the fields `anonymized_text` by removing or anonymizing any personal identifying information while ensuring that key medical concepts and clinical findings remain accurately preserved. The focus is on maintaining as much diagnostic and clinical information as possible while significantly enhancing privacy. Here are comprehensive guidelines and instructions to guide the process:

1. **Identify Personal Identifying Information**:
   - Names (e.g., Mary Smith)
   - Age (e.g., 35 years old)
   - Date (e.g., March 2, 2024)
   - Exact locations (e.g., Boston University Hospital)
   - Specific measurements (e.g., height: 170 cm)

2. **Maintain Clinical Information**:
   - Medical conditions (e.g., diabetes)
   - Gestational age (e.g., 39 weeks)
   - Birth weight (e.g., 3900 grams)
   - Symptoms and findings (e.g., pleuroperitoneal membrane defect)
   - Lab results (e.g., elevated blood glucose levels)
   - Diagnostic procedures (e.g., prenatal ultrasound)
   - Treatment plans (e.g., drug administration)

3. **Examples of Inputs and Expected Outputs**:

   ## Example 1
   ### Input
   A 19-year-old African female refugee has been granted asylum in Stockholm, Sweden and has been living there for the past month. She arrived in Sweden with her 2-month-old infant, whom she exclusively breastfeeds. Which of the following deficiencies is the infant most likely to develop?

   ### Expected Output
   A young female refugee has been granted asylum in Europe and has been living there for the past month. She arrived with her newborn, whom she exclusively breastfeeds. Which of the following deficiencies is the infant most likely to develop?

   ## Feedback
   The anonymized output should preserve the medical condition (Vitamin D deficiency) without identifying the subject's characteristics or location specifically.

   ## Example 2
   ### Input
   A 3900-g (8.6-lb) male infant is delivered at 39 weeks' gestation via spontaneous vaginal delivery. Pregnancy and delivery were uncomplicated but a prenatal ultrasound at 20 weeks showed a defect in the pleuroperitoneal membrane. Further evaluation of this patient is most likely to show which of the following findings?

   ### Expected Output
   A 3900-g male infant is delivered at 39 weeks' gestation via spontaneous vaginal delivery. Pregnancy and delivery were uncomplicated but a prenatal ultrasound at 20 weeks showed a defect in the pleuroperitoneal membrane. Further evaluation of this patient is most likely to show which of the following findings?

   ## Feedback
   The anonymized text should keep the exact medical diagnosis (Pulmonary hypoplasia due to pleuroperitoneal membrane defect) intact.

   ## Example 3
   ### Input
   A P1G0 diabetic woman is at risk of delivering at 30 weeks gestation. Her obstetrician counsels her that there is a risk the baby could have significant pulmonary distress after it is born. However, she states she will administer a drug to the mother to help prevent this from occurring. By what action will this drug prevent respiratory distress in the premature infant?

   ### Expected Output
   A P1G0 pregnant woman is at risk of delivering at 30 weeks gestation. Her obstetrician counsels her that there is a risk the baby could have significant pulmonary distress after it is born. However, she states she will administer a drug to the mother to help prevent this from occurring. By what action will this drug prevent respiratory distress in the premature infant?

   ## Feedback
   Ensure that the medical condition (Extracellular matrix protein expression) remains accurate and preserved in the anonymized version.

4. **Strategy Guidelines**:
   - Replace specific ages with generalized terms (e.g., "a child" instead of "2-month-old").
   - Replace specific location names with more generic terms (e.g., "Sweden" can become "Europe").
   - Maintain medical terminology and clinical observations.
   - Ensure key clinical findings and outcomes are correctly identified and preserved.

5. **Privacy Score Considerations**:
   - Aim for a higher Privacy Score (determined by measures akin to the dissimilarity from the original text).
   - Ensuring that privacy improvements are achieved while accurately preserving clinical information is essential.

Apply these guidelines to generate anonymized texts that effectively balance privacy with the integrity of medical and clinical data. Ensure that the anonymization process does not compromise the diagnostic relevance of the text.
```
